GeneDx Holdings Corp.WGSNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank67
5Y CAGR-42.0%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
-42.0%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 9.55% |
| Q3 2025 | 46.49% |
| Q2 2025 | -8.06% |
| Q1 2025 | 12.05% |
| Q4 2024 | 4.30% |
| Q3 2024 | 2.43% |
| Q2 2024 | 6.69% |
| Q1 2024 | -6.36% |
| Q4 2023 | -1.58% |
| Q3 2023 | -18.39% |
| Q2 2023 | -8.08% |
| Q1 2023 | -21.12% |
| Q4 2022 | -18.89% |
| Q3 2022 | -14.25% |
| Q2 2022 | 43.99% |
| Q1 2022 | -28.28% |
| Q4 2021 | 64.58% |
| Q3 2021 | 94.88% |
| Q2 2021 | -77.12% |
| Q1 2021 | 50.75% |
| Q4 2020 | 145.82% |
| Q3 2020 | 0.00% |